AEON Biopharma, Inc. (AEON) has experienced challenges in growth. The company operates in the Healthcare sector, specifically in the Biotechnology industry.
Historical revenue and profitability trends for AEON Biopharma, Inc.
The chart above illustrates AEON Biopharma, Inc.'s revenue trajectory over the past 4 years. The revenue pattern shows the challenges the company has faced in recent periods.
Annual percentage change in revenue and earnings
Growth rates provide insight into the momentum of AEON Biopharma, Inc.'s business.
How efficiently AEON Biopharma, Inc. converts revenue into profit
Profit margins reveal how much of each dollar of revenue AEON Biopharma, Inc. retains at different stages:
Analyst estimates and forward-looking indicators
Wall Street analysts project AEON Biopharma, Inc. to continue growing earnings in the coming year. The consensus analyst rating is 5 based on 1 analyst.
Based on our comprehensive analysis, AEON Biopharma, Inc. (AEON) demonstrates declining growth characteristics.
This growth analysis provides a comprehensive view of AEON Biopharma, Inc.'s historical performance and future outlook. Investors should consider these growth metrics alongside valuation, competitive positioning, and broader market conditions when making investment decisions. Past performance does not guarantee future results.
See how AEON Biopharma, Inc. stacks up against similar companies
Explore growth analysis for top stocks
Related: AEON Valuation, AEON Dividend, AEON Financial Health
Compare: AEON vs AAPL, AEON vs MSFT, AEON vs GOOGL